Non-antiarrhythmic medications for atrial fibrillation: From bench to clinical practice

Journal of Interventional Cardiac Electrophysiology

Volumn 22, Issue 2, 2008, Pages 119-128

  Guglin, Maya ^a   Garcia, Marcos ^a   Yarnoz, Michael J ^a   Curtis, Anne B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

ACE inhibitors; Atrial fibrillation; Statins

Indexed keywords

ALPHA TOCOPHEROL; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ASCORBIC ACID; ATENOLOL; ATORVASTATIN; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPLERENONE; FENOFIBRATE; HYDRALAZINE; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; ISOSORBIDE MONONITRATE; LISINOPRIL; LOSARTAN; METHYLPREDNISOLONE; OMEGA 3 FATTY ACID; PERINDOPRIL; PLACEBO; PRAVASTATIN; SIMVASTATIN; SPIRONOLACTONE; TRANDOLAPRIL; VALSARTAN;

ADD ON THERAPY; BLOOD PRESSURE REGULATION; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CORONARY ARTERY BYPASS SURGERY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGUS RESECTION; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LUNG RESECTION; MONOTHERAPY; NONHUMAN; PATHOGENESIS; PERICARDITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RECURRENCE;

EID: 48949117530     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-008-9204-7     Document Type: Conference Paper

References (88)

1. A. D. Krahn J. Manfreda R. B. Tate F. A. Mathewson T. E. Cuddy 1995 The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study American Journal of Medicine 98 5 476 484
2. D. G. Wyse A. L. Waldo J. P. DiMarco 2002 Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation New England Journal of Medicine 347 23 1825 1833
3. I. C. Van Gelder V. E. Hagens H. A. Bosker 2002 Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation New England Journal of Medicine 347 23 1834 1840
4. M. Allessie J. Ausma U. Schotten 2002 Electrical, contractile and structural remodeling during atrial fibrillation Cardiovascular Research 54 2 230 246
5. W. B. Kannel P. A. Wolf E. J. Benjamin D. Levy 1998 Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates American Journal of Cardiology 82 8A 2N 9N
6. D. Li S. Fareh T. K. Leung S. Nattel 1999 Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort Circulation 100 1 87 95
7. F. Ravelli M. Allessie 1997 Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart Circulation 96 5 1686 1695
8. A. Ogimoto M. Hamada J. Nakura T. Miki K. Hiwada 2002 Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy Journal of Human Genetics 47 184 189
9. C.-T. Tsai L.-P. Lai J.-L. Lin 2004 Renin-angiotensin system gene polymorphisms and atrial fibrillation Circulation 109 1640 1646
10. P. L'Allier A. Ducharme P. Keller H. Yu M. Guertin J. Tardif 2004 Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Journal of the American College of Cardiology 44 159 164
11. H. Nakashima K. Kumagai H. Urata N. Gondo M. Ideishi K. Arakawa 2000 Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation Circulation 101 2612 2617
12. F. Gensini L. Padeletti C. Fatini E. Sticchi G. Gensini A. Michelucci 2003 Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation PACE 26 2 295 298
13. P. E. McEwan G. A. Gray L. Sherry D. J. Webb C. J. Kenyon 1998 Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo Circulation 98 24 2765 2773
14. A. Goette M. Arndt C. Rocken 2000 Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans Circulation 101 23 2678 2681
15. N. Hanna S. Cardin T. K. Leung S. Nattel 2004 Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure Cardiovascular Research 63 2 236 244
16. A. Goette T. Staack C. Rocken 2000 Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation Journal of the American College of Cardiology 35 1669 1677
17. A. Goette C. Honeycutt J. J. Langberg 1996 Electrical remodeling in atrial fibrillation. Time course and mechanisms Circulation 94 11 2968 2974
18. M. W. Webster M. A. Fitzpatrick M. G. Nicholls H. Ikram J. E. Wells 1985 Effect of enalapril on ventricular arrhythmias in congestive heart failure American Journal of Cardiology 56 8 566 569
19. T. Sumimoto T. Ochi T. Ito T. Joh S. Muneta K. Hiwada 1997 Both a calcium antagonist and ACE inhibitor reverse hypertrophy in hypertension but a calcium antagonist also depresses contractility Cardiovascular Drugs and Therapy 11 1 27 32
20. G. Cannella E. Paoletti R. Delfino G. Peloso D. Rolla S. Molinari 1997 Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects American Journal of Kidney Diseases 30 5 659 664
21. J. Biollaz H. R. Brunner I. Gavras B. Waeber H. Gavras 1982 Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade Journal of Cardiovascular Pharmacology 4 6 966 972
22. J. Staessen P. Lijnen R. Fagard L. J. Verschueren A. Amery 1981 Rise in plasma concentration of aldosterone during long-term angiotensin II suppression Journal of Endocrinology 91 3 457 465
23. A. D. Struthers T. M. MacDonald 2004 Review of aldosterone- and angiotensin II-induced target organ damage and prevention Cardiovascular Research 61 4 663 670
24. P. Milliez X. Girerd P. F. Plouin J. Blacher M. E. Safar J. J. Mourad 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism Journal of the American College of Cardiology 45 8 1243 1248
25. P. Milliez N. Deangelis C. Rucker-Martin 2005 Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction European Heart Journal 26 20 2193 2199
26. R. Gomez L. Nunez R. Caballero M. Vaquero J. Tamargo E. Delpon 2005 Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 minK channels British Journal of Pharmacology 146 1 146 161
27. R. J. MacFadyen C. S. Barr A. D. Struthers 1997 Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients Cardiovascular Research 35 1 30 34
28. M. K. Chung D. O. Martin D. Sprecher O. Wazni A. Kanderian C. A. Carnes 2001 C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 24 2886 2891
29. Mounantonakis, S., Ram, R., Gillinov, M., et al. (2007). Presence of CRP in Left Atrium is Associated with Atrial Fibrillation Irrespective of Serum CRP levels. ACC Scientific Session 2007, E-Poster Session 908.
30. D. Li T. Saldeen F. Romeo J. L. Mehta 2000 Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB Circulation 102 16 1970 1976
31. C. Fatini E. Sticchi F. Gensini 2007 Lone and secondary nonvalvular atrial fibrillation: Role of a genetic susceptibility International Journal of Cardiology 120 59 65
32. T. Yamashita N. Hayami K. Ajiki 1997 Is ACE gene polymorphism associated with lone atrial fibrillation? Japanese Heart Journal 38 5 637 641
33. H. Xiao S. Fuchs D. Campbell W. Lewis S. Dudley V. Kasi 2004 Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death American Journal of Pathology 165 1019 1032
34. M. Gaudino 2003 The -174G/C Interleukin-6 polymorphism influences postoperative Interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108 Suppl II II 95-II-199
35. Y. Shi D. Li J.-C. Tardif S. Nattel 2002 Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure Cardiovascular Research 54 456 461
36. K. Kumagai H. Nakashima H. Urata N. Gondo K. Arakawa K. Saku 2003 Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation Journal of the American College of Cardiology 41 2197 2204
37. D. Li K. Shinagawa L. Pang 2001 Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2608 2614
38. E. Saygili O. Rana E. Saygili 2007 Losartan prevents stretch induced electrical remodeling in cultured atrial neonatal myocytes American Journal of Physiology: Heart and Circulatory Physiology 292 H2898 H2908
39. C. Zhang S. Yasuno K. Kuwahara 2006 Blockade of angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy Circulation Journal 70 335 341
40. S. C. Shroff K. Ryu N. L. Martovitz B. D. Hoit B. S. Stambler 2006 Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure Journal of Cardiovascular Electrophysiology 17 5 534 541
41. K. Kumagai H. Nakashima K. Saku 2004 The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model Cardiovascular Research 62 1 105 111
42. A. Shiroshita-Takeshita G. Schram J. Lavoie 2004 Effect of simvastation and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs Circulation 110 16 2313 2319
43. K. Wachtell M. Lehto E. Gerdts 2005 Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol Journal of the American College of Cardiology 45 712 719
44. L. Hansson L. Lindholm T. Ekbom 1999 Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity. The Swedish Trial in Old Patients with Hypertension-2 Study Lancet 354 1751 1756
45. L. Hansson L. H. Lindholm L. Niskanen 1999 Effect of angiotensin- converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial Lancet 353 9153 611 616
46. J. Healey C. A. Morillo S. J. Connoly 2005 Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling Current Opinion in Cardiology 20 1 31 37
47. S. Williams D. Connely M. Jackson A. Bennett K. Albouaini D. Todd 2005 Does treatment with ACE-inhibitors or angiotensin II receptor antagonists prevent atrial fibrillation after dual chamber pacemaker implantation? Europace 7 554 559
48. A. Maggioni R. Latini P. Carson 2005 Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT) American Heart Journal 149 548 557
49. A. Ducharme K. Swedberg M. A. Pfeffer 2006 Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program American Heart Journal 152 1 86 92
50. E. Vermes J.-C. Tardif M. Bourassa 2003 Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction Circulation 107 2926 2931
51. A. Alsheikh-Ali P. Wang W. Rand 2004 Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction American Heart Journal 147 1061 1065
52. F. Pizzetti F. Turazza M. Franzosi 2001 Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: The GISSI-3 data Heart 86 527 532
53. O. Pedersen H. Bagger L. Kober C. Torp-Pedersen 1999 Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 376 380
54. J. S. Healey A. Baranchuk E. Crystal C. A. Morillo M. Garfinkle S. Yusuf 2005 Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis Journal of the American College of Cardiology 45 11 1832 1839
55. G. Amit A. Katz S. Bar-On 2006 Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker Clinical Cardiology 6 249 252
56. Y. Young-Xu S. Jabbour 2003 Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease American Journal of Cardiology 92 12 1379 1383
57. X. Gao L. Peng C. M. Adhikari J. Lin Z. Zuo 2007 Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure Journal of Cardiac Failure 13 3 170 177
58. I. Brouwer J. Heeringa J. Geleijnse P. Zock J. Witteman 2006 Intake of very long chain n-3 fatty acids from fish and incidence of atrial fibrillation American Heart Journal 151 857 862
59. L. Frost P. Vestergaard 2005 n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study American Journal of Clinical Nutrition 81 50 54
60. K. Teo S. Yusuf P. Sleight C. Anderson F. Mookadam B. Ramos Ontarget/Transcend Investigators 2004 Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE intolerant subjects with cardiovascular disease (Ontarget/Transcend) Trials American Heart Journal 148 1 52 61
61. A. G. Zaman M. T. Kearney C. Schecter S. G. Worthley J. Nolan 2004 Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation American Heart Journal 147 5 823 827
62. M. P. Van Den Berg H. J. Crijns D. J. Van Veldhuisen N. Griep P. J. De Kam K. I Lie 1995 Effects of lisinopril in patients with heart failure and chronic atrial fibrillation Journal of Cardiac Failure 1 5 355 363
63. K.-C. Ueng T.-P. Tsai W.-C. Yu 2003 Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation European Heart Journal 24 2090 2098
64. A. Madrid M. Bueno J. Rebollo 2002 Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study Circulation 106 331 336
65. A. Tveit I. Grundvold M. Olufsen 2007 Candesartan in the prevention of relapsing atrial fibrillation International Journal of Cardiology 120 85 91
66. T. Van Noord H. Crijns M. van den Berg D. Van Veldhuisen I. Van Gelder 2005 Pretreatment with ACE-Is improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation BMC Cardioversion Disorders 5 3
67. M. Loricchio C. Cianfrocca V. Pasceri 2007 Relation of C-reative protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion American Journal of Cardiology 99 1421 1424
68. C. W. Siu C.-P. Lau H. F. Tse 2003 Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion American Journal of Cardiol 92 1343 1345
69. A. Tveit M. Grundtvig 2004 Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion American Journal of Cardiology 93 780 782
70. M. Ozaydin E. Varol S. M. Aslan 2006 Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion American Journal of Cardiology 97 1490 1493
71. W. Anné R. Willems N. Van der Merwe F. Van de Werf H. Ector H. Heidbüchel 2004 atrial fibrillation after radiofrequency ablation of atrial flutter: Preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics Heart 90 1025 1030
72. B. Richter M. Derntl M. Marx P. Lercher H. Gossinger 2007 Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation American Heart Journal 153 113 119
73. Y. Hirayama H. Atarashi Y. Kobayashi 2005 Angiotenisin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation Circulation Journal 69 671 676
74. K. Murray J. Rottman P. Arbogast 2004 Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM Heart Rhythm 1 669 675
75. Y. Yin D. Dalal Z. Liu 2006 Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation European Heart Journal 27 1841 1846
76. J. Dernellis M. Panaretou 2005 Effects of C-reactive protein reduction on paroxysmal atrial fibrillation American Heart Journal 150 5 1064.e7 1064.e12
77. J. Dernellis M. Panaretou 2004 Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation European Heart Journal 25 13 1100 1107
78. Rationale and design of ACTIVE 2006 The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events American Heart Journal 151 1187 1193
79. M. DiSertori R. Latini A. P. Maggioni P. Delise G. Di Pasquale M. G. Franzosi GISSI-AF Investigators 2006 Rationale and design of the GISSI-atrial fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence Journal of Cardiovascular Medicine 7 1 29 38
80. J. P. Mathew M. L. Fontes I. C. Tudor 2004 Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 14 1720 1729
81. C. White J. Kluger K. Lertsburapa O. Faheem C. Coleman 2007 Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III European Journal of Cardiothoracic Surgery 31 817 820
82. C. Coleman S. Makanji J. Kluger M. White 2007 Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation Annals of Pharmacotherapy 41 433 437
83. J. Halonen P. Halonen O. Järvinen 2007 Corticosteroids for the prevention of atrial fibrillation after cardiac surgery JAMA 297 1562 1567
84. G. Patti M. Chello D. Candura 2006 Randomized trial of atorvastatin for the reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhthymia After Cardiac Surgery) Study Circulation 114 1455 1461
85. F. Marin D. A. Pascual V. Roldan 2006 Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting American Journal of Cardiology 97 55 60
86. D. Amar H. Zhang P. Heerdt 2005 Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein Chest 128 3421 3427
87. L. Calo L. Bianconi F. Colivicchi 2005 N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial Journal of the American College of Cardiology 45 10 1723 1728
88. V. Fuster L. E. Rydén D. S. Cannom H. J. Crijns A. B. Curtis K. A. Ellenbogen 2006 ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation Journal of the American College of Cardiology 48 e149 246